Champions Biotechnology establishes UK subsidiary
This article was originally published in Scrip
Champions Biotechnology, a US company developing preclinical platforms and tumour-specific data to enhance the value of oncology drugs, has established a UK subsidiary, Champions Biotechnology UK, to expand its personalised oncology business. Guy Malchi has been appointed general manager of the subsidiary, which will also have a branch in Israel. Mr Malchi has more than 12 years' management experience in the biopharmaceutical industry, having previously served as CEO at Optimata.